Adjusted Morbidity Groups and Intracerebral Haemorrhage: A Retrospective Primary Care Cohort Study.
Blanca Lorman-CarbóJosep Lluís Clua-EspunyEulalia Muria-SubiratsJuan Ballesta-OrsMaria Antònia González-HenaresMeritxell Pallejá-MillánFrancisco Manuel Martín-LujanPublished in: International journal of environmental research and public health (2021)
The Adjusted Morbidity Group 4 is associated with a high risk of intracerebral haemorrhage, particularly for highly complex patients and the use of antiplatelet agents. The risk of bleeding in these patients must be closely monitored.